CEO Thomas M. Frøsig invited as an expert speaker to the Annual Next Gen Immuno-Oncology Congress

Our CEO has been invited as an expert speaker to this year’s Next Gen IO congress, to be held in London March 14.-15. Dr. Frøsig will talk about the need for doing proper immune monitoring and about our established assay for Deep Profiling of Antigen-Specific T cells and our strategy for offering a TCR safety package based on the TCR fingerprinting platform recently published in Nature Biotechnology (Bentzen et al, Nat Biotech December 2018)